#1924 on the rich list of 14,452 insiders
Charles J. Homcy
Director at BridgeBio Pharma; Director at Maze Therapeutics. Based in Palo Alto, California.
$73.2M
in disclosed stock, +$204K (+0.28%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 1924th of 14,452
- Companies held
- 2
- Largest holding
- BBIO, 98.3% of total
- Latest SEC filing
- Jun 22, 2026
What the $73.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| BridgeBio Pharma BBIO Common Stock | Directly | 919,876 | $78.18 | $71.9M | 98.3% | Form 4, Jun 22, 2026 |
| Maze Therapeutics MAZE Common Stock | Directly | 31,113 | $32.43 | $1.0M | 1.4% | Form 4, May 4, 2026 |
| Maze Therapeutics MAZE Common Stock | Through Trust | 7,422 | $32.43 | $241K | 0.3% | Form 4, Nov 19, 2025 |
Share counts are the amounts Charles J. Homcy reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1921 | E. Scott Santi Director, Illinois Tool Works. Glenview, IL | $73.2M |
| 1922 | Benjamin J. Tisch PRES. & CHIEF EXEC. OFFICER, Loews. New York, NY | $73.2M |
| 1923 | Ron Bentsur Chairman & CEO, Nuvectis Pharma. Fort Lee, NJ | $73.2M |
| 1924 | Charles J. Homcy Director, BridgeBio Pharma. Palo Alto, CA | $73.2M |
| 1925 | Patrik Jonsson EVP & President, LLY Int'l, Eli Lilly and. Indianapolis, IN | $73.1M |
| 1926 | Mary Margaret Hastings Georgiadis Director, AppLovin. Palo Alto, CA | $73.1M |
| 1927 | Patrick Drahi Director, Optimum Communications | $73.0M |
Other BridgeBio Pharma insiders
All BBIO insiders- Neil Kumar$438MChief Executive Officer. #525 overall
- Frank McCormick$60.0MDirector. #2239 overall
- Thomas Trimarchi$24.5MPresident and CFO. #4441 overall
- Ali J. Satvat$13.3MDirector. #7082 overall
- Maricel Apuli$9.1MChief Accounting Officer. #9441 overall
- Brian C. Stephenson$8.0MCFO and Treasurer. #9997 overall
Questions
How much stock does Charles J. Homcy own?
Charles J. Homcy holds $73,165,596 in listed stock based on SEC filings and current prices, mostly BridgeBio Pharma (BBIO). That ranks 1924th on the Stock Rich List.
Is this Charles J. Homcy's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.